Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury
Recent studies on liver disease burden worldwide estimated that cirrhosis is the 11th most common cause of death globally, and there is a great need for new therapies to limit the progression of liver injuries in the early stages. Cholestasis is caused by accumulation of hydrophobic bile acids (BA)...
Wedi'i Gadw mewn:
| Prif Awduron: | , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
MDPI AG
2021-07-01
|
| Cyfres: | Cells |
| Pynciau: | |
| Mynediad Ar-lein: | https://www.mdpi.com/2073-4409/10/8/1846 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|